2 Growth Stocks Cathie Wood Is Buying Hand Over Fist
Artificial intelligence (AI) is getting heaps of attention on Wall Street, but that doesn't mean it's the only innovative investment opportunity right now. Shares of plenty of companies that aren't on the cutting edge of AI have been getting scooped up by the Internet's most famous innovation-focused investor, Cathie Wood.
During the first two weeks of June, the CEO of ARK Invest bet heavily on Intellia Therapeutics (NASDAQ: NTLA) and UiPath (NYSE: PATH). Naturally, everyday investors with more modest capital inflows are wondering if they should follow her lead into these growth stocks. Here's what you should know about them before risking any of your hard-earned money.
Image source: Getty Images.
Source Fool.com
Intellia Therapeutics Inc Aktie
Einige Buy-Einschätzungen bei Intellia Therapeutics Inc überwiegen die Sell-Einschätzungen leicht.
Ein Kursziel von 60 € für Intellia Therapeutics Inc deutet auf eine Verdopplung des aktuellen Kurses von 18.0 € hin.